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Abstract
As an integral part of the European Commission (EC)
Imaging Referral Guidelines Project a 1.5-day workshop
was held in Vienna on 20–21 September, 2012. At this
workshop, models and good practices regarding the ap-
propriateness and use of imaging referral guidelines
(Guidelines) in Europe and worldwide were presented,
together with the results of a survey of Guidelines in
Europe. The latter included ideas, innovations and wishes
for future Community action.
Main messages
Recommendations for future Community action:
& Stronger measures should be taken by the EC and the
European competent authorities for making Guidelines
available and used in all EU member states.
& Evidence-based Guidelines with separate guidance for
children should be issued or endorsed by a trusted
European organisation.
& Educational initiatives and electronic requesting in connec-
tion with clinical decision support (CDS) systems should
be used to improve the implementation of Guidelines.
& Monitoring of Guidelines implementation and use should
be by clinical audit, particularly external audit, but also by
local/internal audit.
Introduction
Over 60 participants attended the workshop in Vienna [1], with
registration of representatives from national radiology societies
and representatives from the regulatory bodies of 30 European
countries. Speakers from Europe, USA, Canada and Australia
included expert advisors from the World Health Organisation
(WHO), International Atomic Energy Agency (IAEA) and
European Association of Nuclear Medicine (EANM), as well
as key stakeholders such as representatives from patient groups,
radiographer societies and general practitioners.
The programme included over 30 talks, divided into five
sessions. Each session allowed ample time for discussions,
with enthusiastic participation from the floor.
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Session summaries
The Workshop’s sessions each dealt with a specific subject
within the area of Imaging Referral Guidelines in Europe.
Session 1, Scene Setting , served as an introduction to the
topic and gave an overview on the current status of Referral
Guidelines in Europe. Experts from International
Organisations such as the WHO and IAEA presented their
perspective and invited speakers from Europe, USA, Canada
and Australia shared their views on Referral Guidelines from a
national perspective. This session covered the drivers for the
effective use of Guidelines, followed by the experience from a
number of countries who had developed and used their own
referral guidelines. The key messages included the following:
Drivers for the effective use of Guidelines
European and International Legislation related to radiation
protection requires effective justification of imaging tests in-
volving radiation based on evidence-based guidance [2]. In
addition there are concerns regarding increasing per capita
dose frommedical imaging across Europe and internationally.
On the positive side, earlier access to appropriate imaging is
known to affect outcomes in a number of conditions.
Production of Guidelines
There is a similar process for the production and formatting of
Guidelines by those countries who presented their experience
[3–5], with the exception of Western Australia [6]. Most
countries displayed the Guidelines in a tabular form involving
a grading system but in Western Australia the guidance was
integrated into a decision-making flow-chart algorithm. All
countries reported that the production of evidence-based
Guidelines was resource intensive, particularly in regard to
radiologist input into the process.
There was acknowledgement of duplication of effort, with
the same evidence being reviewed in each individual country
reaching the same or similar conclusions. The ownership and
development of Guidelines by radiologists may well have an
impact on the adoption of, and compliance with, Guidelines
by the end-user clinician.
Challenges in evidence
The evidence base is often related to comparison of differing
modalities in terms of accuracy, safety and efficiency, but
there are less robust data on the impact of the use of imaging
to patient outcomes. Improvements in process are often con-
sidered as a proxy for outcome. Evidence in many pathways is
not always present and, if present, is not always high level,
widely applicable or robust. A key factor should be the overall
efficiency gains within the health system by the correct use of
Guidelines.
Why don’t Guidelines work?
There were common challenges and barriers at the following
stages: awareness, agreement, adoption and adherence.
Specific barriers that were discussed included:
& The total number of Guidelines was seen as a potential
barrier for adoption/adherence—often in excess of 300.
& It was agreed that there had to be ease of access by the end
user at the time of referral, and for this reason paper versions
of the Guidelines were the least effective. Web-based or
App-based Guidelines should in principle improve this.
& Ideally Guidelines should be free to recognised referrers but
this requires a stable financial model for their production.
& Guidelines were often regarded as being owned by the
radiology department or radiologists, with no real owner-
ship by the referrer. In some instances certain clinical
specialties had developed their own guidance as part of
clinical pathways which had the potential to conflict with
the radiology guidelines.
& The increasing concern by referrers of the potential for
litigation if they miss a diagnosis leads to unnecessary
overuse of imaging.
& Patient expectations are continuing to increase and their
insistence on imaging can over-ride clinical judgement.
Solutions
Potential solutions to the barriers and challenges were sug-
gested as follows:
& European or International collaboration on reviewing
evidence.
& Focusing on fewer Guidelines which are likely to have the
biggest impact on safe, quality and efficient care.
& Involve referrer groups in the production and promotion of
Guidelines.
& Integrating Guidelines into the electronic referral pro-
cess—‘decision support’ software.
& Increasing dose awareness as part of the guideline process.
& Improved communication/promotion.
& Focus on improving the evidence base for the Guidelines
that are likely to have the most impact.
& Production of internationally agreed Guidelines with the
ability to customise to national/local circumstances.
& Education/training/audit.
Session 2, Specific Issues , addressed the perspectives of
stakeholders from paediatrics, interventional radiology and
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nuclear medicine, as well as representatives from radiographer
societies and patient groups.
This session gave an excellent overview of referral guide-
lines from the perspectives of varying and diverse stake-




& Radiological protection, both dose issues and risk as well
as implementation issues
& Radiography and the radiographer
& General practitioners
& The patient’s perspective
Not surprisingly all speakers were strongly in favour of
Guidelines although each speaker saw and described their
structure, design and use with differing perspectives.
The key presentation relating to paediatrics stressed the
greater sensitivity of children to radiation-induced effects
and the longer period for effects to be manifested. These
risks were far greater with CT and fluoroscopy, rather than
radiography. Education is essential and the development
and provision of specific guidelines for children is essen-
tial. Discussion centred on whether these should be stand-
alone Guidelines or separate guidelines integrated into a
unified publication.
Interventional radiology is a rapidly changing field hence
the need for frequent updates with practice guidelines for
interventional radiology not fully implemented in current
diagnostic radiology guidelines.
Interventional radiologists act as clinical gatekeepers
ensuring that the design of Guidelines involves multidis-
ciplinary practice, collaboration of a large number of
diverse stakeholders and robust education, not only across
the healthcare community but also to patients, the public
and media.
It was noted that procedural risks in interventional radiol-
ogy were often far higher than radiation-related risks.
Nuclear medicine benefits from fewer procedures and
Guidelines are committee driven and jointly written with
clinical specialities. Interestingly technologists prepare paral-
lel Guidelines. All requests are routinely checked and there is
a strong culture of audit.
The balance between risk and benefit is pivotal, the assess-
ment of dose alone is not helpful and justification requires
knowledge of clinical circumstances. The wording of
Guidelines must be carefully chosen, especially related to
possible risk of misuse, criteria and appropriateness.
Key points of implementation are that Guidelines are
legally required, but more importantly that they are useful,
should be kept up to date, and should be used and audited and
their development funded.
Radiographers were portrayed as playing a key role at the
interface between patient and technology, being the pivot
between referrers, patients and radiologists. They are therefore
a key player in the implementation of referral guidelines.
A presentation from a general practitioner stressed that
excellent communication between the patient, general practi-
tioner and radiologist is essential. This will be facilitated by
clear referral guidelines.
The patient’s perspective stressed the need for dose infor-
mation, clear communication (no acronyms), the need to be
sensitive to the patient’s needs, and that the patient is a
member of the team—“No decision about me without me”.
The varying and diverse interpretation of “Specific
Issues” demonstrates the need for a broad base of knowl-
edge expertise and experience when designing and
implementing Guidelines.
Session 3, Survey Feedback , dealt with the formulation and
findings from the survey of Guidelines in Europe, conducted
as an earlier part of the ECReferral Guidelines Project. Within
this session workshop participants were given an opportunity
to present examples of good practices from their own coun-
tries followed by enthusiastic discussion.
The survey feedback summarised the survey. It was web-
based and involved multiple organisations from 30 countries.
These included radiology and nuclear medicine societies and
competent authorities. The questions were comprehensive and
related to responsibilities, format, circulation and purpose of
the referral guidelines. In addition, the survey participants
were asked to share their views on barriers to implementation
and their potential solutions. In establishing the survey, con-
sideration was given to ease of understanding, completion and
subsequent analysis.
The analysis provided a wealth of data. More significant
information related to awareness of the legal requirement for
Guidelines (60 %) and the difference between this require-
ment and actual availability. There was variation as to the
origin of the Guidelines in each of the countries—some were
based on practice within the Member State, while others were
heavily or entirely based on the publications from organisa-
tions external to their country (e.g. translation of RCR guide-
lines). The survey provided information on a number of key
elements and factors of the Guidelines including the evidence
base, the grading of procedures and the associated radiation
dose.
Session 4 dealt with Innovations for improvement in
Guideline use. Examples of innovations in use worldwide
and potential solutions drawn from other areas of medicine
were discussed.
The needwas identified to improve Guideline development
with specific emphasis on the level of Evidence (currently
approximately 30 % of Guidelines are not evidence-based).
Guidelines should be informed by secondary research and
particularly by systematic reviews where available. There
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was agreement for the need of European Guidelines, either as
a synthesis of several National Guidelines or developed by
European bodies.
Suggestions made for Guideline development include:
& An imaging specialist should be the author.
& Guidelines should be aimed at referrers.
& Guidelines should also be of use to patients and the public.
& Guidelines should be included in the curriculum of med-
ical undergraduates and residents.
The plan for the future should include developments to
electronic requesting (computerised patient order entry,
CPOE) in connection with CDS systems.
The suggestion was made for developing selected high-
impact Guidelines using simple, fast and transparent software,
under the leadership of medical practitioners and validated in
small integrated patient groups by motivated physicians.
Web-based guidance and adequate resources are required. In
addition, tablet and smart phone applications (apps) would be
useful.
Workshop conclusions and recommendations
Following presentations from over 30 speakers and lengthy
discussions at the EuropeanWorkshop,Work Package 2 of the
ECGuidelines Project, a clearer picture of the current situation
has emerged with a coherent message as to the way forward.
Guideline availability and use in Europe
Data to inform the availability of referral guidelines are
not as straightforward as hoped. The survey has shown
discordance of responses between some national compe-
tent authority and professional society representatives,
possibly related to issues of awareness of Guideline exis-
tence and the legal requirement for Guidelines. In addi-
tion, there are issues of access to national guidelines,
which may be related to format or media.
In the European survey [7], respondents in two-thirds of
European countries know of the legal requirement for
Guidelines nationally, and in these countries two-thirds of
these have Guidelines available. Of the one-third of
European countries where there is no awareness of a legal
requirement, only one-third have Guidelines available.
Discussion at the Workshop identified that several countries
had work in progress to update or adopt Guidelines, with
considerable progress since the survey took place, 4 months
previously.
A further, brief, follow-up survey to ascertain the up-to-
date status of Guideline availability was planned following the
Workshop to enable the current work in progress to be
reflected in the final report.
Guideline implementation
Workshop participants agreed that the availability of
Guidelines did not equate with their use. As Guidelines cannot
encompass all clinical scenarios, adherence can only be ex-
pected in up to 90 % of clinical scenarios. Participants at the
Workshop reported that even where Guidelines are available,
their uptake and use are limited. Reasons for this may include:
sub-optimal clinician buy-in, conflicting advice from other
(often clinical) guidelines, and the difficulty associated with
monitoring and encouraging Guideline use.
Tools which can encourage Guideline use include:
& Education—at all levels of training and continuing pro-
fessional development. Web-based, training courses and in-
clusion in curricula as well as educational reminders [8, 9].
These initiatives are already in progress [10].
& CDS systems , particularly those with flexible architecture
to fit existing requesting systems. Examples of CDS sys-
tems were available from many speakers and there was
great interest amongst participants, both radiologists and
regulators.
& Management systems, e.g. Radiological benefit management.
& Governmental incentives , e.g. Payment for performance
[11], Quality Outcome Framework [12].
Monitoring of Guidelines
Measures for reinforcement of Guidelines were considered
essential to provide encouragement for use and to ensure
sustained benefit. The European survey identified models,
particularly external clinical audit as the preferred means, with
a secondary role for local internal audit. Self-regulation
[13, 14] by health professionals and inspection had less support.
Guideline development
Areas of agreement for Guideline development methodology
which were identified from the European survey and consol-
idated at the Workshop are:
& Preference for European Guidelines, which may best be
adapted and amalgamated frommature, trusted, nationally
developed evidence-based guidelines. This option was
considered to be more practical and expeditious than the
centralised development of European Guidelines de novo.
Later iterations of EuropeanGuidelines should encompass
a more inclusive methodology with consensus from ex-
perts from multiple European countries.
12 Insights Imaging (2014) 5:9–13
& Need to include dose information in a form understood by
referrers and patients.
& Separate section for imaging of children.
& Stakeholders, including referrers and patient representa-
tives, should be involved.
& Recommendations based on evidence of efficacy, radia-
tion safety and cost.
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